Overview
This page focuses on how to think about basic dose and exposure concepts in an abstract way for CJC-1295 with DAC and similar peptides. It does not provide dosing instructions or protocols.
Key themes in dosing concepts
- Understanding vial amount, dilution volume, and resulting concentration.
- Relating concentration to an abstract "unit" or hypothetical dose.
- Recognizing that pharmacokinetics (absorption, distribution, metabolism, elimination) influence exposure beyond simple vial math.
Context and caveats
Any concrete dosing decisions for CJC-1295 with DAC must be grounded in product labelling (where it exists), formal clinical guidance, and individualized medical judgment. Educational tools such as calculators and half-life plotters are best treated as aids for understanding, not as dosing engines.
Sport & Anti-Doping Warning
CJC-1295 (a GHRH analogue) has been documented in team-sport doping programs, often paired with GHRP-type secretagogues to boost growth hormone and IGF-1.
- >Cronulla-Sutherland Sharks supplements saga (CJC-1295 and GHRP-6 in NRL)
- >Overview of growth hormone–related peptides on the WADA Prohibited List
Long-acting GH-axis peptides like CJC-1295 are prohibited for WADA-code athletes and have featured in multi-player doping investigations in professional rugby league.